S230: HUMAN ΒETA‐DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT‐VERSUS‐HOST DISEASE by Rückert, T., Andrieux, G., Boerries, M., Woessner, N. M., Minguet, S., Doetsch, S., Aumann, K., Schiff, M, Braun, L. M., Haring, E., Siranosian, B. A., Bhatt, A. S., Nordkild, P., Wehkamp, J., Jensen, B. A. H., Duyster, J., Zeiser, R., Köhler, N.

Get full text

Isoallopregnanolone reduces tic‐like behaviours in the D1CT‐7 mouse model of Tourette syndrome by Cadeddu, Roberto, Bäckström, Torbjörn, Floris, Gabriele, Nordkild, Peter, Segerdahl, Märta, Bortolato, Marco

Get full text

P669 Human β-defensin 2 suppresses TNF-α secretion in human and mouse dendritic cells mediated by chemokine receptor-2 by Armbruster, N S, Sidelmann Brinch, K, Andersen, B, Stange, E F, Malek, N, Nordkild, P, Wehkamp, J

Get full text

P851 Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis by Koeninger, L, Armbruster, N S, Hu, Z, Jensen, B, Stange, E F, Nordkild, P, Malek, N P, Zender, L, Wehkamp, J

Get full text

DOP083 Recombinant subcutaneous human beta-Defensin 2 (hBD2) ameliorates experimental colitis in different in vivo models by Mailänder-Sánchez, D., Kjaerulf, S., Sidelmann Brinch, K., Andersen, B., Stange, E.F., Malek, N., Nordkild, P., Wehkamp, J.

Get full text

Fish oil and antioxidant supplements reduce erythropoietin requirement in haemodialysis patients by Nordkild, P K, Graff, J, Jørgensen, H E, Fugleberg, S

Get full text

Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis by Koeninger, Louis, Armbruster, Nicole S, Brinch, Karoline Sidelmann, Kjaerulf, Søren, Andersen, Birgitte, Langnau, Carolin, Autenrieth, Stella E, Schneidawind, Dominik, Stange, Eduard F, Malek, Nisar P, Nordkild, Peter, Jensen, Benjamin A H, Wehkamp, Jan

Get full text